Translational rewiring downstream of oncogenic signaling (e.g., RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, Wnt/β-catenin) is a key adaptive mechanism in cancer cells that allows specific changes in the proteome to support tumor development, metastasis, and treatment resistance (1, 3). This evidence concerns the gene MTOR and cancer.